Dr Anna Lavelle was appointed as Chair of the Medicines Australia Board in August 2018. Prior to this Dr Lavelle served as Deputy Chair and Independent Director of Medicines Australia from January 2017 to July 2018. Dr Lavelle is an experienced non–executive director, serving for over 25 years on the boards of not for profit, government and for profit entities.  As executive director or non-executive director, she has a lengthy track record in healthcare delivery, technology development and negotiating government policy. From 2005 to 2016, Dr Lavelle was the CEO of AusBiotech, the national industry association for the biotechnology and life sciences sector. She is now serving as Chair of Avatar Brokers Pty Ltd, Non-Executive Director of Hemideina Pty Ltd, Cyban Pty Ltd and Island Pharmaceuticals Ltd, and Independent Director of Sementis Ltd.

Chair, Medicines Australia

DR ANNA LAVELLE

© 2022 APP Conference. All Rights Reserved.

The 2022 Australian Pharmacy Professional Conference is proudly sponsored by: